[HTML] plos.org

[HTML][HTML] Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial

MA Thera, OK Doumbo, D Coulibaly, MB Laurens… - PloS one, 2010 - journals.plos.org
Background The objective was to evaluate the safety and immunogenicity of the AMA1-
based malaria vaccine FMP2. 1/AS02A in children exposed to seasonal falciparum malaria …
被引用次数：92 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children

MA Thera, OK Doumbo, D Coulibaly, MB Laurens… - 2010 - pdfs.semanticscholar.org
Background: The objective was to evaluate the safety and immunogenicity of the AMA1-
based malaria vaccine FMP2. 1/AS02A in children exposed to seasonal falciparum malaria …
[PDF] researchgate.net

[PDF][PDF] Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children

MA Thera, OK Doumbo, D Coulibaly, MB Laurens… - 2010 - researchgate.net
Background: The objective was to evaluate the safety and immunogenicity of the AMA1-
based malaria vaccine FMP2. 1/AS02A in children exposed to seasonal falciparum malaria …

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: Results of a phase 1 randomized controlled trial

MA Thera, OK Doumbo, D Coulibaly… - PLoS …, 2010 - researchers.cdu.edu.au
Background: The objective was to evaluate the safety and immunogenicity of the AMA1-
based malaria vaccine FMP2. 1/AS02 A in children exposed to seasonal falciparum malaria …

Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial

MA Thera, OK Doumbo, D Coulibaly… - PLOS …, 2010 - econpapers.repec.org
Background: The objective was to evaluate the safety and immunogenicity of the AMA1-
based malaria vaccine FMP2. 1/AS02A in children exposed to seasonal falciparum malaria …
[PDF] academia.edu

[PDF][PDF] Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children

MA Thera, OK Doumbo, D Coulibaly, MB Laurens… - 2010 - academia.edu
Background: The objective was to evaluate the safety and immunogenicity of the AMA1-
based malaria vaccine FMP2. 1/AS02A in children exposed to seasonal falciparum malaria …

Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial

MA Thera, OK Doumbo, D Coulibaly, MB Laurens… - PLoS ONE, 2010 - go.gale.com
Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase
1 Randomized Controlled Trial - Document - Gale OneFile: Health and Medicine Use this link …
[PDF] scienceopen.com

[PDF][PDF] Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children

MA Thera, OK Doumbo, D Coulibaly, MB Laurens… - 2010 - scienceopen.com
Background: The objective was to evaluate the safety and immunogenicity of the AMA1-
based malaria vaccine FMP2. 1/AS02A in children exposed to seasonal falciparum malaria …

Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial.

MA Thera, OK Doumbo, D Coulibaly… - PLoS …, 2010 - search.ebscohost.com
Background: The objective was to evaluate the safety and immunogenicity of the AMA1-
based malaria vaccine FMP2. 1/AS02< sub> A in children exposed to seasonal falciparum …

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial

MA Thera, OK Doumbo, D Coulibaly… - PloS …, 2010 - pubmed.ncbi.nlm.nih.gov
Background The objective was to evaluate the safety and immunogenicity of the AMA1-
based malaria vaccine FMP2. 1/AS02 (A) in children exposed to seasonal falciparum …